Idiopathic Myelofibrosis
- 31 October 2005
- journal article
- review article
- Published by Elsevier in Seminars in Hematology
- Vol. 42 (4) , 248-258
- https://doi.org/10.1053/j.seminhematol.2005.05.018
Abstract
No abstract availableKeywords
This publication has 88 references indexed in Scilit:
- A Gain-of-Function Mutation ofJAK2in Myeloproliferative DisordersNew England Journal of Medicine, 2005
- A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia veraNature, 2005
- Durable Responses to Thalidomide-Based Drug Therapy for Myelofibrosis With Myeloid MetaplasiaMayo Clinic Proceedings, 2004
- Therapeutic stem and progenitor cell transplantation for organ vascularization and regenerationNature Medicine, 2003
- Thalidomide in Myelofibrosis with Myeloid Metaplasia: A Pooled-analysis of Individual Patient Data from Five StudiesLeukemia & Lymphoma, 2002
- Myelofibrosis with Myeloid MetaplasiaNew England Journal of Medicine, 2000
- Myelofibrosis with myeloid metaplasia in young indidviduals: disease characteristics, prognostic factors and identification of risk groupsBritish Journal of Haematology, 1998
- Primary myelofibrosis: A detailed statistical analysis of the clinicopathological variables influencing survivalAnnals of Hematology, 1994
- The fibroblast growth factor family: Structural and biological propertiesProgress in Growth Factor Research, 1989
- The Syndrome of Idiopathic MyelofibrosisMedicine, 1983